Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys

MLA

Thomas Wichmann, et al. “Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys.” ACS Chemical Neuroscience, vol. 7, Sept. 2016, pp. 1543–51. EBSCOhost, https://doi.org/10.1021/acschemneuro.6b00186.

APA

Thomas Wichmann, J. Scott Daniels, Gunasingh J. Masilamoni, Adriana Galván, Jocelyn Vuong, Damien Pittard, Craig W. Lindsley, Ryan D. Morrison, & Annaelle Devergnas. (2016). Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys. ACS Chemical Neuroscience, 7, 1543–1551. https://doi.org/10.1021/acschemneuro.6b00186

Chicago

Thomas Wichmann, J. Scott Daniels, Gunasingh J. Masilamoni, Adriana Galván, Jocelyn Vuong, Damien Pittard, Craig W. Lindsley, Ryan D. Morrison, and Annaelle Devergnas. 2016. “Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys.” ACS Chemical Neuroscience 7 (September): 1543–51. doi:10.1021/acschemneuro.6b00186.